Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Hepatogastroenterology ; 58(112): 1877-81, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22024057

RESUMO

BACKGROUND/AIMS: Pancreaticobiliary maljunction (PBM) is a high risk factor in biliary tract cancer. The relation of CD44s and CD44v6 expression in biliary epithelium with PBM and the carcinogenetic process was immunohistochemically examined. METHODOLOGY: One hundred and seven lesions were randomly selected from gallbladders and bile ducts, which were resected from 25 patients with PBM, and immunostaining for CD44s, CD44v6 and MIB-1 was carried out. RESULTS: Among gallbladder lesions, cancerous lesions (dysplasia, cancer) had a higher immunoreactivity with statistical significance for CD44s and CD44v6 compared to non-cancerous lesions (normal, hyperplasia). In bile ducts as well, cancerous lesions had a higher immunoreactivity for CD44s and CD44v6. In both gallbladders and bile ducts, positive cases of CD44s and CD44v6 had a higher statistical significance of Ki-67 labeling index in comparison with negative cases. CONCLUSIONS: In biliary epithelium with PBM, CD44 was indicated to be strongly related to cancer progression via an increase of cellular proliferative potential.


Assuntos
Ductos Biliares/anormalidades , Receptores de Hialuronatos/análise , Ductos Pancreáticos/anormalidades , Adolescente , Adulto , Idoso , Neoplasias dos Ductos Biliares/química , Criança , Pré-Escolar , Progressão da Doença , Feminino , Neoplasias da Vesícula Biliar/química , Humanos , Receptores de Hialuronatos/fisiologia , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Ubiquitina-Proteína Ligases/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...